MB, Levis & Associates’s iShares iBonds Dec 2036 Term Corporate ETF IBCB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBCB
MB, Levis & Associates's IBCB Position: Q3 2026 in Review
MB, Levis & Associates increased its iShares iBonds Dec 2036 Term Corporate ETF (IBCB) stake by 42% in Q3 2026, buying an estimated $5.66M and bringing the position to 782,135 shares worth $18.5M. The position accounts for 6.78% of the portfolio, ranked #3.
MB, Levis & Associates first reported a position in IBCB in Q2 2026 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold IBCB as of Q3 2026.
- MB, Levis & Associates held 782,135 shares of iShares iBonds Dec 2036 Term Corporate ETF worth $18.5M as of Q3 2026.
- MB, Levis & Associates bought 231,022 iShares iBonds Dec 2036 Term Corporate ETF shares in Q3 2026, an estimated $5.66M.
- iShares iBonds Dec 2036 Term Corporate ETF made up 6.78% of MB, Levis & Associates's portfolio in Q3 2026, its #3 holding.
- MB, Levis & Associates first reported a position in iShares iBonds Dec 2036 Term Corporate ETF in Q2 2026 and has held it in 2 quarters since.
- 16 funds tracked by Wall St. Rank held iShares iBonds Dec 2036 Term Corporate ETF as of Q3 2026.
Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.